July 2026
M	T	W	T	F	S	S
	1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

EHC: Recognizing Von Willebrand Factor as a Critical Medicine in Bleeding Care

The European Haemophilia Consortium / X

Jul 10, 2025, 18:11

EHC: Recognizing Von Willebrand Factor as a Critical Medicine in Bleeding Care

The European Haemophilia Consortium (EHC) recently shared a post on X:

”Von Willebrand Disease affects 1:1000 individuals and, if not recognised, may cause severe bleeding symptoms after trauma or surgery that can be life-threatening. It’s time for health systems to recognise Von Willebrand Factor as a Critical Medicine. European Medicines Agency”

Von Willebrand Disease (VWD), the most common inherited bleeding disorder, affects approximately 1 in 1,000 individuals.

When unrecognized or untreated, it can lead to serious, even life-threatening bleeding, particularly after trauma or surgical procedures.

Despite its prevalence and potential severity, VWD remains underdiagnosed and undertreated in many health systems.

There is an urgent need to designate Von Willebrand Factor (VWF) as a Critical Medicine to ensure timely diagnosis, treatment access, and improved outcomes for patients.

Recognizing VWF’s essential role in bleeding management is a key step toward better care for individuals living with VWD worldwide.

Hemostasis Today, your daily update on the waves in bleeding disorders community.